Atyr Pharma Inc (NASDAQ:ATYR) traded at $3.98 at close of the session on Friday, January 03 and made an upward move of 1.79% on its previous day’s price.
Looking at the stock we see that its previous close was $3.91 and the beta (5Y monthly) reads 1.101 with the day’s price range being $3.83 – $4.02. In terms of its 52-week price range, ATYR has a high of $3.98 and a low of $1.39. The company’s stock has gained about 19.52% over that past 30 days.
Atyr Pharma Inc has a market cap of $340.07 million and is expected to release its quarterly earnings report in February.
On the other hand, looking at the outlook for the ATYR stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 100% Buy.
Looking further, we note the current price level is 17.42% off its SMA20 and 21.12% from its 50-day simple moving average. The RSI (14) is pointing at 68.25 while the volatility over the past week is 7.56% and jumps to 7.33% over the past one month. The beta value is 1.09, while the average true range (ATR) is currently pointing at 0.25.
Coming back to Atyr Pharma Inc (NASDAQ:ATYR), we note that the average 3-month trading volume was 1.07 million, while that of the preceding 10-day period stands at 1.03 million. Current shares outstanding are 83.94 million.
The insiders hold 2.36% of the company’s shares while institutions hold 63.01%. The data shows that short shares as of 2024-12-13, stood at 2.92 million at a short ratio of 3.71. This represents a 458.00 short interest in shares outstanding on 2024-12-13. Shares short rose in December from the previous month at 2.11 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 9.94% up in year-to-date price movement.
